Literature DB >> 33669459

Prevalent ALMS1 Pathogenic Variants in Spanish Alström Patients.

Brais Bea-Mascato1,2, Carlos Solarat1,2, Irene Perea-Romero3,4, Teresa Jaijo3,5, Fiona Blanco-Kelly3,4, José M Millán3,5, Carmen Ayuso3,4, Diana Valverde1,2.   

Abstract

Alström syndrome (ALMS) is an ultrarare disease with an estimated prevalence lower than 1 in 1,000,000. It is associated with disease-causing mutations in the Alström syndrome 1 (ALMS1) gene, which codifies for a structural protein of the basal body and centrosomes. The symptomatology involves nystagmus, type 2 diabetes mellitus (T2D), obesity, dilated cardiomyopathy (DCM), neurodegenerative disorders and multiorgan fibrosis. We refined the clinical and genetic diagnosis data of 12 patients from 11 families, all of them from Spain. We also studied the allelic frequency of the different variants present in this cohort and performed a haplotype analysis for the most prevalent allele. The genetic analysis revealed 2 novel homozygous variants located in the exon 8, p.(Glu929Ter) and p.(His1808GlufsTer20) in 2 unrelated patients. These 2 novel variants were classified as pathogenic after an in silico experiment (computer analysis). On the other hand, 2 alleles were detected at a high frequency in our cohort: p.(Tyr1714Ter) (25%) and p.(Ser3872TyrfsTer19) (16.7%). The segregation analysis showed that the pathogenic variant p.(Tyr1714Ter) in 3 families is linked to a rare missense polymorphism, p.(Asn1787Asp). In conclusion, 2 novel pathological mutations have been discovered in homozygosis, as well as a probable founder effect in 3 unrelated families.

Entities:  

Keywords:  Alström syndrome; ciliopathies; founder effect; metabolic disease; novel mutations

Mesh:

Substances:

Year:  2021        PMID: 33669459      PMCID: PMC7920446          DOI: 10.3390/genes12020282

Source DB:  PubMed          Journal:  Genes (Basel)        ISSN: 2073-4425            Impact factor:   4.096


  27 in total

1.  Alström Syndrome: Mutation Spectrum of ALMS1.

Authors:  Jan D Marshall; Jean Muller; Gayle B Collin; Gabriella Milan; Stephen F Kingsmore; Darrell Dinwiddie; Emily G Farrow; Neil A Miller; Francesca Favaretto; Pietro Maffei; Hélène Dollfus; Roberto Vettor; Jürgen K Naggert
Journal:  Hum Mutat       Date:  2015-05-18       Impact factor: 4.878

2.  Alms1-disrupted mice recapitulate human Alström syndrome.

Authors:  G B Collin; E Cyr; R Bronson; J D Marshall; E J Gifford; W Hicks; S A Murray; Q Y Zheng; R S Smith; P M Nishina; J K Naggert
Journal:  Hum Mol Genet       Date:  2005-07-06       Impact factor: 6.150

Review 3.  Genealogy, natural history, and phenotype of Alström syndrome in a large Acadian kindred and three additional families.

Authors:  J D Marshall; M D Ludman; S E Shea; S R Salisbury; S M Willi; R G LaRoche; P M Nishina
Journal:  Am J Med Genet       Date:  1997-12-12

4.  Exome sequencing establishes diagnosis of Alström syndrome in an infant presenting with non-syndromic dilated cardiomyopathy.

Authors:  Pamela A Long; Jared M Evans; Timothy M Olson
Journal:  Am J Med Genet A       Date:  2015-02-23       Impact factor: 2.802

5.  Mutations in ALMS1 cause obesity, type 2 diabetes and neurosensory degeneration in Alström syndrome.

Authors:  Gayle B Collin; Jan D Marshall; Akihiro Ikeda; W Venus So; Isabelle Russell-Eggitt; Pietro Maffei; Sebastian Beck; Cornelius F Boerkoel; Nicola Sicolo; Mitchell Martin; Patsy M Nishina; Jürgen K Naggert
Journal:  Nat Genet       Date:  2002-04-08       Impact factor: 38.330

6.  Predicting the functional effect of amino acid substitutions and indels.

Authors:  Yongwook Choi; Gregory E Sims; Sean Murphy; Jason R Miller; Agnes P Chan
Journal:  PLoS One       Date:  2012-10-08       Impact factor: 3.240

7.  Alström syndrome: genetics and clinical overview.

Authors:  Jan D Marshall; Pietro Maffei; Gayle B Collin; Jürgen K Naggert
Journal:  Curr Genomics       Date:  2011-05       Impact factor: 2.236

8.  Characterization of Alstrom Syndrome 1 (ALMS1) Transcript Variants in Hodgkin Lymphoma Cells.

Authors:  Katarina Braune; Ines Volkmer; Martin S Staege
Journal:  PLoS One       Date:  2017-01-30       Impact factor: 3.240

9.  High quality, patient centred and coordinated care for Alstrom syndrome: a model of care for an ultra-rare disease.

Authors:  Stephanie Van Groenendael; Luca Giacovazzi; Fabian Davison; Oliver Holtkemper; Zexin Huang; Qiaoying Wang; Kay Parkinson; Timothy Barrett; Tarekegn Geberhiwot
Journal:  Orphanet J Rare Dis       Date:  2015-11-24       Impact factor: 4.123

10.  Monogenic diabetes syndromes: Locus-specific databases for Alström, Wolfram, and Thiamine-responsive megaloblastic anemia.

Authors:  Dewi Astuti; Ataf Sabir; Piers Fulton; Malgorzata Zatyka; Denise Williams; Carol Hardy; Gabriella Milan; Francesca Favaretto; Patrick Yu-Wai-Man; Julia Rohayem; Miguel López de Heredia; Tamara Hershey; Lisbeth Tranebjaerg; Jian-Hua Chen; Annabel Chaussenot; Virginia Nunes; Bess Marshall; Susan McAfferty; Vallo Tillmann; Pietro Maffei; Veronique Paquis-Flucklinger; Tarekign Geberhiwot; Wojciech Mlynarski; Kay Parkinson; Virginie Picard; Gema Esteban Bueno; Renuka Dias; Amy Arnold; Caitlin Richens; Richard Paisey; Fumihiko Urano; Robert Semple; Richard Sinnott; Timothy G Barrett
Journal:  Hum Mutat       Date:  2017-06-01       Impact factor: 4.878

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.